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Abstract 
 
Aims 
Improved survival has resulted in increasing numbers and complexity of adults with 
congenital heart disease (ACHD). International guidelines recommend specialized care 
but many patients are still not managed at dedicated ACHD centres. This study analysed 
referral sources and appropriateness of management for patients referred to our tertiary 
ACHD Centre over the past 3 years.  
 
Methods and Results 
We compared differences in care between patients referred from paediatric/ACHD-
trained versus general adult cardiologists, according to Adherence (A) or Non-Adherence 
(NA) with published guidelines. NA cases were graded according to the severity of 
adverse outcome or risk of adverse outcome. Of 309 consecutively referred patients (28 ± 
14 years, 51% male), 134 (43%) were from general cardiologists (19% highly complex 
CHD) and 115 (37%) were from paediatric cardiology or ACHD specialists (33% highly 
complex CHD). Sixty referrals (20%) were from other medical teams and of those, 31 
had been lost to follow-up. Guideline deviations were more common in referrals from 
general compared to CHD-trained cardiologists (p<0.001). Of general cardiology 
referrals, 49 (37%) were NA; 18 had catastrophic or major complications (n=2,16 
respectively). By contrast, only 12 (10%) of the paediatric/ACHD referrals were NA but 
none of these were catastrophic and only 3 were major. Simple, moderate and highly 
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complex CHD patients were at increased risk of adverse outcome when not under CHD 
cardiology care (p=0.04, 0.009 and 0.002 respectively).  
 
Conclusion 
Non-adherence with guidelines was common in the ACHD population, and this 
frequently resulted in important adverse clinical consequences. These problems were 
more likely in patients who had not been receiving specialized CHD care. Configuring 
healthcare systems to optimise “whole of life” care for this growing population is 
essential. 
 
Keywords 
Congenital heart disease, transition, adult congenital heart disease, lost to follow-up, 
disease management 
 
Abbreviations 
ACHD - adult congenital heart disease, A - adherent, CHD - congenital heart disease, NA 
- non-adherent 
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Introduction 
 
Delivering “whole of life” care for children born with complex medical problems 
is a substantial issue for all developed health care systems. Paediatric cardiologists 
traditionally deal with congenital heart issues, whereas adult cardiologists are trained in 
acquired heart diseases such as atherosclerosis and hypertension. This creates a potential 
problem for “whole of life” care when children with congenital heart disease (CHD), in 
whom there have often been enormous medical, financial and emotional investments 
made, transition to care as young adults.  
 
Advances in surgical and medical care have led to rapid growth in the number and 
complexity of adults living with CHD, resulting in challenges to health care systems and 
potentially to deficiencies of care.1 As a result, this growing patient group is at 
substantially increased risk of important morbidity and premature mortality.2 Many of the 
underlying medical issues are uncommon or do not occur in adults with acquired heart 
disease. In recent years therefore, the need for delivery of expert care in specialized adult 
congenital heart disease (ACHD) centres has been recognized.3,4  
 
Current international guidelines recommend that all but the most simple 
congenital cardiac defects are managed, at least intermittently, by a cardiologist with 
ACHD training.4-6 When applied, this model of care has been associated with reduced 
mortality. 7,8 Nevertheless, many patients are still solely under the care of general 
cardiologists rather than at specialized centers. The reasons for this are not well 
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characterized but might include geographic barriers and lack of sufficient ACHD 
centers.9  
 
To our knowledge, the clinical consequences of the management of ACHD 
patients by generally trained versus CHD-trained cardiologists have not been reported. To 
understand the impact on patient care for this vulnerable and growing group of young 
adults, we sought to characterize the consequences for patient care according to 
compliance or otherwise with international ACHD care guidelines.5,6 
 
Methods 
 
Study Design 
Consecutive new referrals (≥16 years) to the major ACHD centre in Sydney, 
Australia from January 2013 to January 2016 were screened for inclusion. Prospectively 
defined exclusion criteria were uncomplicated bicuspid aortic valve disease or mitral 
valve prolapse. This study complies with the declaration of Helsinki. The database 
utilized for data collection has been approved by the Sydney Local Health District Ethics 
Review Committee (RPAH Zone). Individual consent waiver was granted. 
 
CHD was classified as simple, moderately or highly complex in accordance with 
current ACC/AHA published guidelines.5 Each subject was classified by their most 
clinically important lesion, to facilitate analysis.  
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Referral sources were categorized as either CHD-cardiologist (paediatric or ACHD), 
general cardiologist, or other medical team (e.g. obstetric, general practitioner).  A CHD 
cardiologist was defined as a cardiologist with at least 1 year of dedicated speciality 
training in CHD. Cardiologists without at least 1 year of formal CHD training were 
classified as general for the purposes of the study. Patients referred by other medical 
teams, who had been previously managed by a CHD-cardiologist but had been lost to any 
form of regular cardiology follow-up (> 3 years), were considered as “lost to follow-up”. 
Patients returning for review who were managed under a shared care model with our 
service were not considered to be a new referral and thus they were not included. Clinical 
notes including letters and results of investigations performed prior to referral, were 
retrospectively reviewed by 2 cardiologists with expertise in ACHD. For subjects who 
were under the care of a cardiologist, patient management at the time of referral based 
upon the “initial appointment” clinical notes and investigations arranged at that visit, 
were classified according to adherence or non-adherence with published guidelines.5,6,10-
12 Patients referred directly when CHD was first identified were classified as  “Adherent”. 
“Non-adherent” cases were graded according to the nature of the adverse outcome arising 
or the risk of adverse outcome, in accordance with local and international standards for 
risk assessment and classification of consequences:13,14 
 
1. Catastrophic - Death, near-death, permanent disability or loss of cardiac function 
with high likelihood of reducing life expectancy, inappropriate termination of 
pregnancy or advice to have termination. 
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2. Major - Permanent loss of cardiac function that poses significant risk to patient, 
recommended unnecessary intervention or failure to recommend necessary 
intervention with potential to expose patient to unnecessary risk of death or 
permanent loss of cardiac function, inappropriately advised against pregnancy. 
3. Moderate - Less serious risk or inappropriate advice/treatment administered 
where the impact to patient is less serious and risk of death or permanent loss of 
cardiac function is unlikely. 
4. Minor - failure to meet guidelines concerning investigation and treatment.  
 
The grading of adverse outcome was agreed upon by both ACHD cardiologists. If 
there was uncertainty about the grade, the lowest or less important level was allocated. 
De-indentified details of adverse events were then reviewed by an external CHD-
cardiologist to minimise subjectivity. Once again, if there was disagreement, the lower 
grade was allocated.  
 
New referrals who had never been under the care of any adult cardiologist were not 
included in analysis of compliance with clinical care guidelines. Only grade 1-3 adverse 
outcomes are reported in patients who had been lost to cardiology follow-up. 
 
Statistical Analysis 
 
Descriptive data are presented as mean ± standard deviation. Comparisons 
between groups were made using Chi-squared testing for categorical variables and 
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Students t-testing for continuous variables. A two-sided p-value < 0.05 was considered 
significant. Logistic regression analyses were performed in new referrals from 
cardiologists to determine the predictors of adverse outcome (Grade 1-3 guideline 
deviation). Values produced were odds ratio, 95% confidence interval of the odds ratio, 
the overall p-value and the C-statistic along with its 95% confidence interval.  Statistical 
analyses were performed using IBM SPSS Statistics, Version 22.0.  
 
Results 
 
Over the 3-year enrolment period, there were 309 consecutive referred patients 
who met the inclusion criteria. New referral characteristics are shown in Table 1. 
Simplified CHD categories are shown in Table 2. Of the non-cardiology referrers, 45 
(15%) were the general practitioner/primary healthcare provider and 15 (5%) were other 
medical teams.  
 
All referrals from CHD-specialists were for transition from paediatric services 
(108 or 94% of specialized CHD referrals, at age 20 ± 10 years, range 16-37 years) or 
relocation from other cities (5 patients).  
 
Of patients referred from general cardiologists or other non-CHD trained doctors, 
128 (66%) were for a specialist CHD opinion in the absence of new symptoms, 34 (17%) 
were for advice regarding new imaging findings, 19 (10%) were because of the 
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development of a new clinical problem, 10 were for advice related to pregnancy (5%) and 
3 (2%) were for advice with regard to arrhythmia management.  
 
Thirty-one of the 60 non-cardiology referrals (50%, representing 10% of the 
entire new referral cohort) had been lost to cardiac follow-up (for ≥ 3 years). Of those, 11 
were simple (35%), 15 were moderately complex (48%) and 5 were highly complex 
(17%) CHD patients.   
 
Overall, care was adherent with current guidelines in 187 of 249 patients who had 
been under regular cardiology follow-up (75%). 61 patients (25%) were classified as non-
adherent (Figure 1a). Of the patients referred from CHD-cardiologists, 12 (10%) were 
non-adherent, but no consequences were catastrophic, 3 (2%) were major, 2 (2%) were 
moderate and 7 (6%) were minor.  In contrast, 49 (37%) general cardiology referrals were 
non-adherent; 18 (14%) had catastrophic or major issues (n=2 and 16 respectively), 17 
(13%) had moderately important and 14 (10%) had minor deviations from guidelines. 
Deviations from guidelines were substantially more common in referrals from general 
compared to CHD-trained cardiology referrals (p<0.001), as were catastrophic/major 
complications (p=0.002).  
 
The impact of CHD complexity on the rate of guideline deviation is shown in 
Figure 1b. In patients referred by cardiologists, no catastrophic or major adverse events 
occurred in patients with simple congenital heart disease. Overall, patients with complex 
CHD (moderately or highly complex) were more likely to have had deviations from 
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clinical care guidelines, compared with simple CHD patients (29% vs. 9%, p<0.001). 
Grade 1-3 (catastrophic/major/moderate) adverse outcomes were also more common in 
complex CHD cases (20% vs. 6%, p<0.001).  
 
Catastrophic, major and moderate complications in new referrals from 
cardiologists are described in Table 3; the most common catastrophic/major adverse 
outcome overall occurred in the setting of free pulmonary regurgitation after repair of 
tetralogy of Fallot or obstructive right heart lesions.  
 
The results of multivariable analyses for new cardiology referrals are shown in 
Table 4. The C-statistic for the model was 0.78 (0.72-0.85). Being under the care of a 
general cardiologist, age ≥ 30 years and complex CHD were independent predictors of 
Grade 1-3 adverse outcomes. 
 
Thirty-one (10%) new referrals were referred back to specialized CHD care 
having been lost to any kind of cardiology follow-up ≥ 3 years (age at referral 29 ± 9 
years, 52% female); of these, 3 (10%) had catastrophic complications, 1 (3%) had a 
major complication and 1(3%) had a moderately serious complication. Catastrophic and 
major complications were more likely to occur in patients who had been lost to follow-up 
compared with those who had remained under specialized CHD care (13% vs. 3%, 
p=0.02).  Catastrophic complications in these patients included sudden death due to aortic 
aneurysm in repaired coarctation (n=1), resuscitated cardiac arrest (ventricular 
tachycardia) in the setting of severe pulmonary regurgitation and right ventricular 
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dilatation after repair for tetralogy of Fallot (n=1) and cardiogenic shock and stroke 
complicating severe aortic regurgitation with left ventricular dysfunction in congenital 
aortic stenosis after open-valvotomy (n=1).  There was one major adverse issue in a 
patient with very severe systemic ventricular dysfunction and ventricular tachycardia 
after Mustard repair and one moderate adverse outcome in a patient with severe 
pulmonary regurgitation after tetralogy of Fallot repair, who had severe right ventricular 
dilatation. 
 
Discussion 
 
We have found that management of adults with CHD outside specialist ACHD 
centres is associated with a high risk of important adverse events, and these are related to 
deviations from clinical care guidelines.  
 
The great success of paediatric cardiac care in recent decades has created a 
challenge for healthcare systems to provide equivalent excellent levels of care for this 
growing population of adult survivors, who often have complex cardiac disease. This is 
the first study, to our knowledge, to document the rate of deviation from guidelines in the 
management of ACHD patients, to classify this according to the referral source and to 
document the clinical consequences of such deviations. Our findings support current 
guidelines4-6 that recommend expert care for such patients and emphasise the need for 
adequate service provision for this rapidly expanding and vulnerable population.1 
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In order to optimise “whole of life” outcomes, health systems will need to be configured 
to provide access to specialized care for adults with CHD. In Australia and the United 
Kingdom, for example, guidelines have recently been published which recommend the 
requirement for networks of care which include specialized centres, to provide national 
cover.15,16 Each country needs to consider specific transition and ACHD care solutions, 
according to existing demographic, medical training and systems factors. 
 
In our study, the most common referral source was general adult cardiologists; 
this comprised almost half of new referrals. Three quarters of those referred were 
moderately or highly complex CHD patients. In comparison, only 37% of new referrals 
were from CHD-trained cardiologists the vast majority of those whom were transitioning 
from paediatric to adult CHD services (71% were moderately or highly complex). These 
data suggest that a large number of adults with CHD are being managed outside 
specialized CHD centres, despite current recommendations.5,6 Clinically important 
adverse events of moderate to catastrophic severity occurred in only 4% of referrals from 
CHD-trained sources (none catastrophic), compared with 26% in referrals from general 
cardiologists, despite the more complex case mix for the specialist referrals (33% of 
highly complex patients versus 19% highly complex, amongst the general cardiology 
referrals). Thus current referral and management patterns of children born with CHD may 
result in suboptimal clinical outcomes, which can be catastrophic. Potential solutions to 
this problem are organisational and education-related.  
 
 13 
There are three possible “fates” for children with CHD as they become adults; 
referral to ACHD-trained specialists; loss to follow-up; or referral to general adult 
cardiologists without specific ACHD expertise.  
 
Our data show that when there is successful transition from paediatric cardiology 
to ACHD care, errors that result in adverse clinical consequences are rare. The challenge, 
however, is to optimise the transition of care process to minimise loss of patients. Even in 
the most experienced CHD centres, transition to ACHD care fails in up to 50% of cases;17 
this is likely due to a combination of inadequately designed interservice transition 
arrangements and to patient-related factors (such as adolescent rebellion, a desire to be 
“normal” and/or financial constraints, especially in countries without universal health 
care coverage).17 Whatever the reason, loss to ACHD follow up is associated with 
markedly increased mortality and morbidity.18 In our study, 10% of new referrals were 
patients who had been lost to specialized CHD care (for ≥ 3 years). This number of 
complex patients lost to CHD-trained care is likely to be markedly underestimated as we 
do not know about ACHD patients who were never referred to an expert centre but 
continued to be managed by a general cardiologist (or physician) only, or who were 
under no cardiology care at all. Ten percent of our “lost to follow-up” patients had 
catastrophic complications, emphasising the great need for improved transition 
arrangements for adolescents. Potential solutions include paediatric CHD registries and 
mechanisms for patient recall; patient education and engagement; and provision of an 
adequate and trained workforce to implement such programs.3,17,19  
 
 14 
We found that many children with CHD are ultimately cared for by general 
cardiologists. This is also the case in many other regions, including North America and 
the United Kingdom.17,20,21 In our study, general cardiology care was associated with 
substantial non-compliance with care guidelines, often with serious consequences for the 
patient. Solutions to this issue include improved education in ACHD during adult 
cardiology training, easy access for general cardiologists to ACHD centres for advice (via 
care networks) and models of shared care, especially for rural and remote ACHD 
patients.  
 
Adverse events were more common in patients with moderately or highly 
complex CHD but even patients with simple CHD had an increased risk of adverse 
outcome, supporting recommendations that encourage at least intermittent CHD-trained 
cardiology assessment for these patients.5,6 These data are likely to underlie the 
improvement in survival demonstrated in Canada, after the implementation of guidelines 
that recommended specialized ACHD care for patients with complex CHD.7 Our 
evidence from the Australia and New Zealand Fontan Registry has also demonstrated that 
non-specialized care is associated with increased risk of serious complications, in the 
particularly challenging group of adults with “single ventricle” hearts.8 
 
The commonest “errors” we observed were related to underestimation of 
pulmonary regurgitation, a common late consequence of repaired tetralogy of Fallot or 
right heart obstruction. In this setting delayed treatment of pulmonary regurgitation 
exposes patients to risks of adverse cardiac remodelling, ventricular arrhythmia and 
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death, in the setting of severe right ventricular dilatation.22 This observation is consistent 
with data from the United Kingdom that demonstrated the proportion patients with 
repaired tetralogy of Fallot who received pulmonary valve replacement was much lower 
in those receiving general follow-up compared with those with specialized CHD care.20 
When considered as proportion of lesion-type, high numbers of adverse events were also 
noted from non-compliance in relation to unrepaired intracardiac shunts, repaired 
coarctation or interrupted aortic arch, Ebstein’s anomaly, repaired atrioventricular septal 
defect, Mustard/Senning repair for transposition of the great arteries and complex single 
ventricle patients. 
 
Based on prevalence estimates from developed countries, there are likely at least 
2000 CHD children per million children aged 8 to 18 years, who will require adult care 
for severe CHD, over the next 10 years.1 Our data suggest that care at a specialized 
ACHD Centre rather than by general cardiologists could avoid approximately 40 000 
adverse events over 10 years, in developed countries alone (that is, approximately 400 
adverse clinical events for every 2000 patients who transition to adult care). This number 
would be even greater if adults with CHD who are already under general cardiology care 
and less severe CHD patients were to be included.  
 
Limitations 
 
A limitation of this study is potential selection bias. We only studied those 
patients who were eventually referred to an ACHD Centre; those lost to follow up 
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entirely would not have been included. Thus the true picture of late adverse clinical 
outcomes has likely been underestimated in our study. Another potential limitation is the 
methodology used for interpretation of the severity of adverse outcomes related to non-
compliance with published guidelines. We attempted to minimise subjectivity or bias by 
using internationally recognized tools to grade adverse outcome,13 down-grading any 
adverse event when a consensus was not achieved between specialist assessors and 
including an external, blinded assessor. It is likely that advancing age is associated with 
an increased incidence of cardiac complications and, since general cardiology referrals 
were older on average, this may have biased the results. On multivariable analysis, 
however, we found that referral from a general cardiologist was predictive of adverse 
outcome independent of patient age at the time of referral. Our data is from a single 
ACHD centre in Australia and practices may differ internationally, but our outcomes for 
patients with some of the most complex congenital heart disease are excellent by 
international standards23 and the issues we have highlighted are supported by recent data 
from North America and the United Kingdom.17,18,20 The reasons for non-compliance 
with guidelines may not simply be related to physician-related factors; patients may 
decline intervention or be non-compliant with medical recommendations. To address this 
issue, care was classified as adherent if the physician had proposed guideline-directed 
management, even if the plan was not implemented. Also, clinical status could have 
changed between the last review prior to referral and the first review at our centre, 
however this should have been equally likely, from any referral source (CHD trained or 
general).  Finally, we acknowledge that “guidelines” only guide management decisions, 
which sometimes require modification according to individual patient factors. 
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Conclusions 
 
The rapidly expanding ACHD population is at risk of a complex array of issues 
that require specialized care.24 We have found that a significant proportion of the ACHD 
cohort had received care that was not adherent with guidelines, and that this led 
frequently to adverse consequences which were far more common in referrals from 
general cardiologists than in referrals from practitioners with CHD training and expertise; 
with over one quarter of patients from “non-specialists” having adverse clinical events.  
Patients who were lost to any kind of cardiology follow-up were at a similarly increased 
risk of major or catastrophic complications. Optimising health care systems to enable 
adequate access to specialized ACHD service provision for this growing population is 
essential. 
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Figure Title and Legend: 
 
Figure 1) a and b Guideline Deviations in New Adult Referrals to a Specialized 
Congenital Heart Disease Centre: Incidence, Clinical Implications and Impact of 
Complexity. Statistical comparison reported for combined analysis of moderate to 
catastrophic complications 
 
Table Titles 
Table 1 
New Referrals and Frequency of Non-Compliance with Clinical Guidelines 
Abbreviations: CHD - congenital heart disease, TGA - transposition of the great arteries 
 
Table 2: Congenital Heart Defect Categories with Grade 1-3 Adverse Outcomes 
Referred from Cardiologists  - Frequency and Issue 
 
Table 3 
Predictors of Grade 1-3 Adverse Outcomes in Referrals from Cardiologists 
Abbreviations: CHD - congenital heart disease 
 
